Comments
Loading...

Macrogenics Analyst Ratings

MGNXNASDAQ
Logo brought to you by Benzinga Data
$1.51
-0.07-4.43%
At close: -
$1.50
-0.00990-0.66%
After Hours: 7:04 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$17.00
Lowest Price Target1
$2.00
Consensus Price Target1
$8.11

Macrogenics Analyst Ratings and Price Targets | NASDAQ:MGNX | Benzinga

Macrogenics Inc has a consensus price target of $8.11 based on the ratings of 14 analysts. The high is $17 issued by Stifel on November 27, 2023. The low is $2 issued by HC Wainwright & Co. on March 25, 2025. The 3 most-recent analyst ratings were released by B. Riley Securities, Stifel, and Barclays on May 20, 2025, May 14, 2025, and May 14, 2025, respectively. With an average price target of $3.67 between B. Riley Securities, Stifel, and Barclays, there's an implied 144.43% upside for Macrogenics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B. Riley Securities
Stifel
Barclays
HC Wainwright & Co.
Citigroup

1calculated from analyst ratings

Analyst Ratings for Macrogenics

Buy NowGet Alert
05/20/2025Buy Now99.99%B. Riley Securities
Mayank Mamtani71%
$5 → $3MaintainsNeutralGet Alert
05/14/2025Buy Now233.31%Stifel
Stephen Willey48%
$6 → $5MaintainsHoldGet Alert
05/14/2025Buy Now99.99%Barclays
Peter Lawson41%
$8 → $3MaintainsOverweightGet Alert
03/25/2025Buy Now33.32%HC Wainwright & Co.
Robert Burns44%
$4 → $2MaintainsNeutralGet Alert
11/07/2024Buy Now—JMP Securities
Silvan Tuerkcan47%
—DowngradeMarket Outperform → Market PerformGet Alert
11/06/2024Buy Now166.65%HC Wainwright & Co.
Robert Burns44%
$4 → $4ReiteratesNeutral → NeutralGet Alert
09/18/2024Buy Now166.65%HC Wainwright & Co.
Robert Burns44%
$4 → $4ReiteratesNeutral → NeutralGet Alert
08/21/2024Buy Now166.65%HC Wainwright & Co.
Robert Burns44%
$4 → $4ReiteratesNeutral → NeutralGet Alert
08/15/2024Buy Now833.27%Citigroup
Yigal Nochomovitz54%
$16 → $14MaintainsBuyGet Alert
08/07/2024Buy Now233.31%BMO Capital
Etzer Darout45%
$8 → $5MaintainsMarket PerformGet Alert
08/01/2024Buy Now—BTIG
Kaveri Pohlman27%
—DowngradeBuy → NeutralGet Alert
08/01/2024Buy Now166.65%HC Wainwright & Co.
Robert Burns44%
$4 → $4ReiteratesNeutral → NeutralGet Alert
07/31/2024Buy Now433.3%JMP Securities
Silvan Tuerkcan47%
$16 → $8MaintainsMarket OutperformGet Alert
07/31/2024Buy Now433.3%Barclays
Peter Lawson41%
$9 → $8MaintainsOverweightGet Alert
07/31/2024Buy Now—Guggenheim
Kelsey Goodwin34%
—DowngradeBuy → NeutralGet Alert
07/31/2024Buy Now233.31%B. Riley Securities
Mayank Mamtani71%
$18 → $5DowngradeBuy → NeutralGet Alert
07/29/2024Buy Now499.96%Barclays
Peter Lawson41%
$14 → $9MaintainsOverweightGet Alert
05/24/2024Buy Now499.96%BTIG
Kaveri Pohlman27%
$24 → $9MaintainsBuyGet Alert
05/13/2024Buy Now166.65%HC Wainwright & Co.
Robert Burns44%
$16 → $4MaintainsNeutralGet Alert
05/10/2024Buy Now833.27%Barclays
Peter Lawson41%
$25 → $14MaintainsOverweightGet Alert
05/10/2024Buy Now966.6%JMP Securities
Silvan Tuerkcan47%
$22 → $16MaintainsMarket OutperformGet Alert
05/10/2024Buy Now433.3%BMO Capital
Etzer Darout45%
$24 → $8DowngradeOutperform → Market PerformGet Alert
05/10/2024Buy Now—TD Cowen
Boris Peaker49%
—DowngradeBuy → HoldGet Alert
05/10/2024Buy Now366.64%Stifel
Stephen Willey48%
$29 → $7DowngradeBuy → HoldGet Alert
04/09/2024Buy Now—TD Cowen
Boris Peaker49%
—UpgradeHold → BuyGet Alert
04/04/2024Buy Now—JMP Securities
Silvan Tuerkcan47%
—Reiterates → Market OutperformGet Alert
03/11/2024Buy Now1566.56%Citigroup
Yigal Nochomovitz54%
$13 → $25MaintainsBuyGet Alert
03/11/2024Buy Now1366.57%JMP Securities
Silvan Tuerkcan47%
$16 → $22MaintainsOutperformGet Alert
03/11/2024Buy Now966.6%HC Wainwright & Co.
Robert Burns44%
$14 → $16MaintainsNeutralGet Alert
03/08/2024Buy Now1499.89%BMO Capital
Etzer Darout45%
$18 → $24MaintainsOutperformGet Alert
03/08/2024Buy Now1833.2%Stifel
Stephen Willey48%
$17 → $29MaintainsBuyGet Alert
03/08/2024Buy Now1566.56%Barclays
Peter Lawson41%
$23 → $25MaintainsOverweightGet Alert
03/04/2024Buy Now1499.89%BTIG
Kaveri Pohlman27%
$12 → $24MaintainsBuyGet Alert
02/29/2024Buy Now1433.23%Barclays
Peter Lawson41%
$12 → $23MaintainsOverweightGet Alert
02/14/2024Buy Now833.27%HC Wainwright & Co.
Robert Burns44%
$12 → $14DowngradeBuy → NeutralGet Alert
01/24/2024Buy Now966.6%JMP Securities
Silvan Tuerkcan47%
$10 → $16MaintainsMarket OutperformGet Alert
12/20/2023Buy Now766.61%Citigroup
Yigal Nochomovitz54%
$7 → $13UpgradeNeutral → BuyGet Alert
11/27/2023Buy Now1033.26%Stifel
Jonathan Block72%
→ $17ReiteratesBuy → BuyGet Alert
11/13/2023Buy Now699.95%HC Wainwright & Co.
Robert Burns44%
$14 → $12MaintainsBuyGet Alert
11/07/2023Buy Now699.95%Guggenheim
Charles Zhu26%
→ $12UpgradeNeutral → BuyGet Alert
08/10/2023Buy Now833.27%HC Wainwright & Co.
Robert Burns44%
→ $14ReiteratesBuy → BuyGet Alert
05/11/2023Buy Now566.62%JMP Securities
Silvan Tuerkcan47%
$8 → $10MaintainsMarket OutperformGet Alert
04/03/2023Buy Now833.27%HC Wainwright & Co.
Robert Burns44%
→ $14Reiterates → BuyGet Alert
03/21/2023Buy Now699.95%BTIG
Kaveri Pohlman27%
$6 → $12MaintainsBuyGet Alert
03/20/2023Buy Now833.27%HC Wainwright & Co.
Robert Burns44%
$12 → $14MaintainsBuyGet Alert
03/17/2023Buy Now—Guggenheim
Charles Zhu26%
—DowngradeBuy → NeutralGet Alert
03/16/2023Buy Now433.3%JMP Securities
Silvan Tuerkcan47%
→ $8Reiterates → Market OutperformGet Alert
01/19/2023Buy Now433.3%JMP Securities
Silvan Tuerkcan47%
$18 → $8MaintainsMarket OutperformGet Alert
11/23/2022Buy Now366.64%Citigroup
Yigal Nochomovitz54%
$16 → $7DowngradeBuy → NeutralGet Alert
11/23/2022Buy Now699.95%Guggenheim
Charles Zhu26%
→ $12UpgradeNeutral → BuyGet Alert
11/22/2022Buy Now—Cowen & Co.
Boris Peaker49%
—DowngradeOutperform → Market PerformGet Alert
11/14/2022Buy Now966.6%BMO Capital
Etzer Darout45%
$5.7 → $16UpgradeMarket Perform → OutperformGet Alert
11/07/2022Buy Now699.95%HC Wainwright & Co.
Robert Burns44%
$11 → $12MaintainsBuyGet Alert
10/18/2022Buy Now633.28%HC Wainwright & Co.
Robert Burns44%
$10 → $11MaintainsBuyGet Alert
09/12/2022Buy Now566.62%HC Wainwright & Co.
Robert Burns44%
$35 → $10MaintainsBuyGet Alert
08/29/2022Buy Now966.6%Citigroup
Yigal Nochomovitz54%
$13 → $16MaintainsBuyGet Alert
08/09/2022Buy Now699.95%SVB Leerink
Jonathan Chang39%
$15 → $12MaintainsOutperformGet Alert
08/09/2022Buy Now433.3%Barclays
Peter Lawson41%
$18 → $8MaintainsOverweightGet Alert
07/12/2022Buy Now1233.24%JMP Securities
Silvan Tuerkcan47%
$24 → $20MaintainsMarket OutperformGet Alert
07/12/2022Buy Now166.65%BMO Capital
Etzer Darout45%
$31 → $4DowngradeOutperform → Market PerformGet Alert
07/11/2022Buy Now166.65%BMO Capital
Etzer Darout45%
$31 → $4DowngradeOutperform → Market PerformGet Alert

FAQ

Q

What is the target price for Macrogenics (MGNX) stock?

A

The latest price target for Macrogenics (NASDAQ:MGNX) was reported by B. Riley Securities on May 20, 2025. The analyst firm set a price target for $3.00 expecting MGNX to rise to within 12 months (a possible 99.99% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Macrogenics (MGNX)?

A

The latest analyst rating for Macrogenics (NASDAQ:MGNX) was provided by B. Riley Securities, and Macrogenics maintained their neutral rating.

Q

When was the last upgrade for Macrogenics (MGNX)?

A

The last upgrade for Macrogenics Inc happened on April 9, 2024 when TD Cowen raised their price target to N/A. TD Cowen previously had a hold for Macrogenics Inc.

Q

When was the last downgrade for Macrogenics (MGNX)?

A

The last downgrade for Macrogenics Inc happened on November 7, 2024 when JMP Securities changed their price target from N/A to N/A for Macrogenics Inc.

Q

When is the next analyst rating going to be posted or updated for Macrogenics (MGNX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Macrogenics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Macrogenics was filed on May 20, 2025 so you should expect the next rating to be made available sometime around May 20, 2026.

Q

Is the Analyst Rating Macrogenics (MGNX) correct?

A

While ratings are subjective and will change, the latest Macrogenics (MGNX) rating was a maintained with a price target of $5.00 to $3.00. The current price Macrogenics (MGNX) is trading at is $1.50, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch